B Nebbad
Overview
Explore the profile of B Nebbad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klebsiella aerogenes-related facial folliculitis in men having sex with men: A hypothetical new STI?
Berot V, Monsel G, Dauendorffer J, Aubry A, Nebbad B, Schneider P, et al.
J Eur Acad Dermatol Venereol
. 2024 Apr;
39(1):e10-e12.
PMID: 38619375
No abstract available.
2.
Houist A, Lafont C, Gomart C, Nebbad B, Bartolucci P, Vindrios W, et al.
Infect Dis Now
. 2022 Mar;
52(4):202-207.
PMID: 35259497
Objective: Tuberculosis (TB) disease has rarely been reported in patients with sickle cell disease, but it is associated with an increased risk of bacterial infections. In France, sickle cell disease...
3.
Couffin S, Lobo D, Cook F, Jost P, Bitot V, Birnbaum R, et al.
Eur J Clin Microbiol Infect Dis
. 2018 Jan;
37(4):755-763.
PMID: 29353379
The epidemiology of healthcare-associated meningitis (HAM) is dominated by commensal bacteria from the skin, as coagulase-negative staphylococci (CoNS). We hypothesized that the pauci-symptomatic and mild inflammatory patterns of HAM are...
4.
de Risi-Pugliese T, Servy A, Decousser J, Nebbad B, Desroches M, Wolkenstein P, et al.
Br J Dermatol
. 2017 Apr;
177(4):e154-e155.
PMID: 28369801
No abstract available.
5.
Jolivet S, Fines-Guyon M, Nebbad B, Merle J, Le Pluart D, Brun-Buisson C, et al.
J Hosp Infect
. 2016 Oct;
94(4):346-350.
PMID: 27726900
Background: Vancomycin-resistant Enterococcus raffinosus has rarely been associated with nosocomial infection and outbreaks. Aim: To report the successful control of a nosocomial outbreak of vanA-type vancomycin-resistant E. raffinosus in a...
6.
Le Joncour A, Bidegain F, Ziol M, Nebbad B, Galicier L, Oksenhendler E, et al.
Clin Infect Dis
. 2016 May;
63(3):428.
PMID: 27161782
No abstract available.
7.
Eckert C, Emirian A, Le Monnier A, Cathala L, De Montclos H, Goret J, et al.
New Microbes New Infect
. 2015 Mar;
3:12-7.
PMID: 25755885
Clostridium difficile causes antibiotic-associated diarrhoea and pseudomembranous colitis. The main virulence factors of C. difficile are the toxins A (TcdA) and B (TcdB). A third toxin, called binary toxin (CDT),...
8.
Bingen E, Mariani-Kurkdjian P, Nebbad B
Med Mal Infect
. 2006 Oct;
36(9):439-42.
PMID: 17027219
Vancomycin is the cornerstone of therapy against methicillin-resistant Staphylococus aureus in both community and nosocomial-acquired infections. Because vancomycin is a concentration-independent or time-dependant antibiotic, most clinicians have abandoned the routine...